Child Neurology Society's Brainstorm cover image

CNS Brainstorm Episode 48 "Pediatric NF1 Therapeutics" with guest Bonnie Kaur, MD

Child Neurology Society's Brainstorm

00:00

MEK inhibitors mechanism explained

Bonnie Kaur describes selumetinib and mirdametinib as MEK inhibitors that block RAS-RAF-MEK-ERK signaling to stop tumor growth.

Play episode from 02:28
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app